DIABETIC MACULAR EDEMA
-
Eylea offers equivalent efficacy with fewer injections for wet AMD, DME management: Dr Ashish Gawde
The most pressing challenges include the financial and emotional burdens associated with frequent, long-term treatments for conditions such as Diabetic Macular Edema (DME) and Wet Age-related Macular Degeneration (AMD).
-
Diabetic Macular Edema & Diabetic Retinopathy: The unseen risk
-
Roche launches Vabysmo to treat neovascular AMD, DME in India
-
Roche launches top selling eye drug Vabysmo in India
-
'Step therapy' effective strategy for diabetic eye disease: Study
-
Early diagnosis can prevent loss of vision due to diabetes: Dr. Mahipal Sachdev, Medical Director & Chairman, Centre for Sight Group of Eye Hospitals
-
Recent Advancements in Eye Care
-
Bayer's Aflibercept injection gets DCGI nod for Diabetic Macular Edema indication
-
U.S. FDA declines to approve pre-filled syringe version of Regeneron's Eylea
Join the community of 2M+ industry professionals
Subscribe to our Daily Newsletter
Advertisement
Advertisement
Get updates on your preferred social platform
Follow us for the latest news, insider access to events and more.
